1-3 of 3
Gioia Colafigli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival and Response Rates after a 10-Year Follow-up of Chronic Myeloid Leukemia Patients in Chronic Phase Treated with Imatinib in a Real-Life Practice

Matteo Molica, MD, Emilia Scalzulli, MD, Alunni Fegatelli Danilo, Roberto Latagliata, Gioia Colafigli, MD, Lorenzo Rizzo, Daniela Diverio, Robin Foà, MD, Massimo Breccia, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1741.
https://doi.org/10.1182/blood-2018-99-116486
Published: 2018
Journal Articles

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Daniela De Benedittis, MD, Massimo Breccia, MD, Ida Carmosino, Elena Mariggiò, MD, Matteo Molica, MD, Sara Mohamed, MD, Fulvio Massaro, MD, Maria Lucia De Luca, MD, Emilia Scalzulli, MD, Chiara Lisi, MD, Mauro Passucci, MD, Gioia Colafigli, MD, Maria Giovanna Loglisci, MD, Daniela Diverio, Marco Mancini, Robin Foà, MD, Roberto Latagliata
Journal: Blood
Blood (2018) 132 (Supplement 1): 1746.
https://doi.org/10.1182/blood-2018-99-117272
Published: 2018
Journal Articles

Does Bone Marrow Fibrosis Play a Role in the Prognostication of Newly Diagnosed Polycythemia Vera Patients?

Matteo Molica, MD, Daniela De Benedictis, MD, Emilia Scalzulli, MD, Ida Carmosino, Laura Cesini, Marta Chisini, MD, Maria Lucia De Luca, MD, Fulvio Massaro, MD, Gioia Colafigli, MD, Marco Mancini, Stefania Trasarti, MD, Massimo Breccia, MD PhD, Robin Foa, MD, Roberto Latagliata
Journal: Blood
Blood (2017) 130 (Supplement 1): 4184.
https://doi.org/10.1182/blood.V130.Suppl_1.4184.4184
Published: 2017